Unknown

Dataset Information

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth.


ABSTRACT:

Background

Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear.

Methods

The expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The prognostic value of DRD3 in patients was investigated by analyzing selected databases, including cBioPortal and Kaplan-Meier plotter. Cell growth was tested by CCK8 assay, and Transwell assays were performed to assess cancer cell migration and invasion. The cAMP/ERK/CREB signaling pathway was evaluated by Western blot analysis and ELISA. An HCC xenograft model was established for in vivo experiments.

Results

DRD3 mRNA expression was significantly higher in nontumor tissues than in tumo

SUBMITTER: Yan Y 

PROVIDER: S-EPMC9717446 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature